2026-01-22 - Analysis Report
**Company Overview**
Align Technology is a medical device company that designs, manufactures, and markets a range of dental alignment and smile enhancement products.

**Return Rate Comparison**

| Stock | Cumulative Return |
| --- | --- |
| ALGN (Review Stock) | -47.41% |
| VOO (S&P 500 Comparison Stock) | 91.55% |
| Divergence | -140.20 (difference in cumulative return) |

The cumulative return of the S&P 500 (VOO) is significantly higher than the review stock (ALGN). The divergence is currently -140.20, indicating a relatively large gap between the two stocks.

**Performance Analysis**

| Period | CAGR | MDD | Alpha | Beta | Market Capitalization (B) |
| --- | --- | --- | --- | --- | --- |
| 2016-2018 | 47.0% | 48.8% | 42.0% | 1.5 | 15.2 |
| 2017-2019 | 69.0% | 50.2% | 51.0% | 1.6 | 20.2 |
| 2018-2020 | -23.0% | 50.2% | -44.0% | 1.5 | 38.7 |
| 2019-2021 | 16.0% | 45.1% | -28.0% | 1.5 | 47.6 |
| 2020-2022 | -108.0% | 75.2% | -106.0% | 1.5 | 15.3 |
| 2021-2023 | -138.0% | 75.2% | -139.0% | 1.7 | 19.9 |
| 2022-2024 | -79.0% | 64.3% | -99.0% | 1.7 | 15.1 |
| 2023-2025 | -25.0% | 57.2% | -87.0% | 1.5 | 11.3 |

The performance of ALGN has been volatile, with significant losses in some periods and gains in others. The CAGR (Compound Annual Growth Rate) has been negative in some periods, indicating a decline in value over time.

**Recent Stock Price Fluctuations**

| Indicator | Value |
| --- | --- |
| Close | $169.95 |
| 5-day SMA | $169.54 |
| 20-day SMA | $164.41 |
| 60-day SMA | $152.06 |

The stock price has been fluctuating around the 5-day and 20-day SMAs, indicating a range-bound market.

**RSI, PPO Index Indicators**

| Indicator | Value |
| --- | --- |
| RSI | 66.08 |
| PPO | -0.18 |
| Market Risk Indicator (MRI) | 0.80 |

The RSI (Relative Strength Index) is above 60, indicating a bullish trend. The PPO (Percentage Price Oscillator) is negative, indicating a bearish trend. The MRI is 0.80, indicating a medium risk level.

**News & Significant Events**

* [2026-01-21] Align Tech (ALGN) Receives a Hold from UBS - The Globe and Mail
* [2026-01-17] Assessing Align Technology (ALGN) Valuation After Recent Share Price Rebound And Modest Discount Signals - simplywall.st
* [2026-01-14] 3 Reasons to Avoid ALGN and 1 Stock to Buy Instead - Yahoo Finance
* [2026-01-20] Mizuho Maintains "Outperform" Rating for ALGN, Raises Price Target - GuruFocus
* [2025-10-30] Why Align Technology Stock Popped Today - The Motley Fool
* [2025-10-30] Align Technology Stock Forecast: Where Analysts See the Stock by 2027 - TIKR.com

**Analyst Opinions**

Analyst Consensus:
* Key: Buy
* Mean (1=StrongBuy~5=Sell): 2.17 (~Buy)
* Opinions: 15
* Target Price (avg/high/low): 182.47 / 220.00 / 150.00

**Recent Earnings Analysis**

| Date | EPS | Revenue |
| --- | --- | --- |
| 2025-11-05 | 0.78 | $1.00 B |
| 2025-08-06 | 1.72 | $1.01 B |
| 2025-05-08 | 1.27 | $0.98 B |
| 2024-11-05 | 1.55 | $0.98 B |
| 2025-11-05 | 1.55 | $0.98 B |

The company's earnings have been volatile, with significant changes in EPS and revenue over the past year.

**Financial Information**

**Revenue and Profitability**

| Quarter | Revenue | Profit Margin |
| --- | --- | --- |
| 2025-09-30 | $1.00B | 64.20% |
| 2025-06-30 | $1.01B | 69.94% |
| 2025-03-31 | $0.98B | 69.45% |
| 2024-12-31 | $1.00B | 70.03% |
| 2024-09-30 | $0.98B | 69.72% |

**Capital and Profitability**

| Quarter | Equity | ROE |
| --- | --- | --- |
| 2025-09-30 | $3.96B | 1.43% |
| 2025-06-30 | $3.91B | 3.18% |
| 2025-03-31 | $3.79B | 2.46% |
| 2024-12-31 | $3.85B | 2.69% |
| 2024-09-30 | $3.94B | 2.94% |

The company's revenue and profit margin have been declining over the past year, while its equity and ROE (Return on Equity) have been increasing.

**Comprehensive Analysis**

Based on the analysis of the company's performance, recent stock price fluctuations, and financial information, it appears that ALGN has been experiencing significant volatility in its stock price and earnings over the past year. The cumulative return of the S&P 500 (VOO) is significantly higher than the review stock (ALGN), indicating a relatively large gap between the two stocks. The performance analysis suggests that the company's CAGR has been negative in some periods, indicating a decline in value over time. However, the recent stock price fluctuations indicate a range-bound market. The RSI is above 60, indicating a bullish trend, while the PPO is negative, indicating a bearish trend. The MRI is 0.80, indicating a medium risk level. The company's earnings have been volatile, with significant changes in EPS and revenue over the past year. Overall, the analysis suggests that ALGN is a high-risk stock with significant volatility in its stock price and earnings over the past year.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.